Ruth Greferath

795 total citations
15 papers, 664 citations indexed

About

Ruth Greferath is a scholar working on Molecular Biology, Physiology and Cancer Research. According to data from OpenAlex, Ruth Greferath has authored 15 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Physiology and 4 papers in Cancer Research. Recurrent topics in Ruth Greferath's work include Neuroinflammation and Neurodegeneration Mechanisms (3 papers), HIV Research and Treatment (2 papers) and Carcinogens and Genotoxicity Assessment (2 papers). Ruth Greferath is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (3 papers), HIV Research and Treatment (2 papers) and Carcinogens and Genotoxicity Assessment (2 papers). Ruth Greferath collaborates with scholars based in United States, France and Germany. Ruth Greferath's co-authors include Claude Nicolau, Konstantina C. Fylaktakidou, Jean‐Maríe Lehn, Geoffrey C. Gurtner, Dennis R. Alford, P.F. Tosi, Charles E. Larsen, David Spragg, Michael A. Gimbrone and Kyung‐Dall Lee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Oncogene and Environmental Health Perspectives.

In The Last Decade

Ruth Greferath

15 papers receiving 646 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruth Greferath United States 11 291 168 124 77 71 15 664
Sarah Kohn Israel 12 309 1.1× 58 0.3× 120 1.0× 49 0.6× 59 0.8× 20 647
Kimiko Takahashi Japan 13 308 1.1× 64 0.4× 126 1.0× 37 0.5× 127 1.8× 27 701
Federico Corti United States 16 403 1.4× 182 1.1× 106 0.9× 19 0.2× 111 1.6× 24 808
Marion David France 18 626 2.2× 94 0.6× 119 1.0× 50 0.6× 179 2.5× 33 1.2k
Elizabeth Monaghan-Benson United States 14 398 1.4× 81 0.5× 123 1.0× 16 0.2× 107 1.5× 20 700
Katarina Jansson Sweden 14 217 0.7× 59 0.4× 50 0.4× 30 0.4× 31 0.4× 19 547
S M Danilov Russia 15 346 1.2× 154 0.9× 60 0.5× 53 0.7× 72 1.0× 26 780
Paraskevi Andriopoulou Greece 7 461 1.6× 143 0.9× 116 0.9× 14 0.2× 94 1.3× 8 815
Maria Hersom Denmark 9 267 0.9× 88 0.5× 71 0.6× 49 0.6× 83 1.2× 10 760
Françoise Frérart Belgium 10 467 1.6× 164 1.0× 365 2.9× 60 0.8× 76 1.1× 10 956

Countries citing papers authored by Ruth Greferath

Since Specialization
Citations

This map shows the geographic impact of Ruth Greferath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Greferath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Greferath more than expected).

Fields of papers citing papers by Ruth Greferath

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth Greferath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Greferath. The network helps show where Ruth Greferath may publish in the future.

Co-authorship network of co-authors of Ruth Greferath

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth Greferath. A scholar is included among the top collaborators of Ruth Greferath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth Greferath. Ruth Greferath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Thinard, Reynald, Attila E. Farkas, Marta Hałasa, et al.. (2022). “Endothelial Antibody Factory” at the Blood Brain Barrier: Novel Approach to Therapy of Neurodegenerative Diseases. Pharmaceutics. 14(7). 1418–1418. 3 indexed citations
2.
Heller, Loreé C., et al.. (2020). Secretion of proteins and antibody fragments from transiently transfected endothelial progenitor cells. Journal of Cellular and Molecular Medicine. 24(15). 8772–8778. 9 indexed citations
3.
Pencreach, Erwan, Marc Aprahamian, Elisabeth Martin, et al.. (2012). Increasing the oxygen load by treatment with myo-inositol trispyrophosphate reduces growth of colon cancer and modulates the intestine homeobox gene Cdx2. Oncogene. 32(36). 4313–4318. 25 indexed citations
4.
Aprahamian, Marc, Chérif Akladios, Konstantina C. Fylaktakidou, et al.. (2011). Myo‐InositolTrisPyroPhosphate Treatment Leads to HIF‐1α Suppression and Eradication of Early Hepatoma Tumors in Rats. ChemBioChem. 12(5). 777–783. 32 indexed citations
5.
Duarte, Carolina D., Ruth Greferath, Claude Nicolau, & J.-M. Lehn. (2010). myo‐Inositol Trispyrophosphate: A Novel Allosteric Effector of Hemoglobin with High Permeation Selectivity across the Red Blood Cell Plasma Membrane. ChemBioChem. 11(18). 2543–2548. 29 indexed citations
6.
Biolo, Andréia, Ruth Greferath, Deborah A. Siwik, et al.. (2009). Enhanced exercise capacity in mice with severe heart failure treated with an allosteric effector of hemoglobin, myo -inositol trispyrophosphate. Proceedings of the National Academy of Sciences. 106(6). 1926–1929. 45 indexed citations
7.
Muhs, Andreas, David T. Hickman, Maria Pihlgren, et al.. (2007). Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice. Proceedings of the National Academy of Sciences. 104(23). 9810–9815. 140 indexed citations
8.
Kiéda, Claudine, Ruth Greferath, Claire Crola Da Silva, et al.. (2006). Suppression of hypoxia-induced HIF-1α and of angiogenesis in endothelial cells by myo -inositol trispyrophosphate-treated erythrocytes. Proceedings of the National Academy of Sciences. 103(42). 15576–15581. 42 indexed citations
9.
Fylaktakidou, Konstantina C., Jean‐Maríe Lehn, Ruth Greferath, & Claude Nicolau. (2005). Inositol tripyrophosphate: a new membrane permeant allosteric effector of haemoglobin. Bioorganic & Medicinal Chemistry Letters. 15(6). 1605–1608. 41 indexed citations
10.
Nicolau, Claude, et al.. (2002). A liposome-based therapeutic vaccine against β-amyloid plaques on the pancreas of transgenic NORBA mice. Proceedings of the National Academy of Sciences. 99(4). 2332–2337. 38 indexed citations
11.
Greferath, Ruth & Peter Nehls. (1997). Monoclonal Antibodies to Thymidine Glycol Generated by Different Immunization Techniques. Hybridoma. 16(2). 189–193. 2 indexed citations
12.
Nehls, Peter, Frank Seiler, B. Rehn, Ruth Greferath, & J. Bruch. (1997). Formation and persistence of 8-oxoguanine in rat lung cells as an important determinant for tumor formation following particle exposure.. Environmental Health Perspectives. 105(suppl 5). 1291–1296. 56 indexed citations
13.
Nehls, Peter, Frank Seiler, B. Rehn, Ruth Greferath, & J. Bruch. (1997). Formation and Persistence of 8-Oxoguanine in Rat Lung Cells as an Important Determinant for Tumor Formation Following Particle Exposure. Environmental Health Perspectives. 105. 1291–1291. 8 indexed citations
14.
Spragg, David, Dennis R. Alford, Ruth Greferath, et al.. (1997). Immunotargeting of liposomes to activated vascular endothelial cells: A strategy for site-selective delivery in the cardiovascular system. Proceedings of the National Academy of Sciences. 94(16). 8795–8800. 175 indexed citations
15.
Reszka, Regina, et al.. (1995). Liposome Mediated Transfer of Marker and Cytokine Genes Into Rat and Human Glioblastoma Cells in Vitro and in Vivo. Journal of Liposome Research. 5(1). 149–167. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah Kohn Breakdown of academic impact, for papers by Kimiko Takahashi Breakdown of academic impact, for papers by Federico Corti Breakdown of academic impact, for papers by Marion David Breakdown of academic impact, for papers by Elizabeth Monaghan-Benson Breakdown of academic impact, for papers by Katarina Jansson Breakdown of academic impact, for papers by S M Danilov Breakdown of academic impact, for papers by Paraskevi Andriopoulou Breakdown of academic impact, for papers by Maria Hersom Breakdown of academic impact, for papers by Françoise Frérart
Rankless by CCL
2026